The oxygen sparing effect of bacteriotherapy in COVID-19 (1)

The probiotic Slab51 (Sivomixx®800, Ormendes, Switzerland) has been evaluated in sixty-nine adult COVID-19 patients with a confirmed diagnosis of SARS-CoV-2 related pneumonia a CT lung involvement greater than 50 percent and requiring non-invasive oxygen therapy. Patients supplemented with Slab51 in addition to standard therapy (n=40) showed significantly higher blood levels of partial [...]